InvestorsHub Logo
Followers 32
Posts 6953
Boards Moderated 0
Alias Born 11/15/2010

Re: None

Saturday, 09/24/2016 12:49:27 PM

Saturday, September 24, 2016 12:49:27 PM

Post# of 1309
Probably a correction coming. Roche wouldn't be in Barcelona talking about Ocrevus--Ocrelizumab--on October 10, at the European Committee For Treatment and Research of Multiple Sclerosis if they didn't have something good to say. And odds seem to favor our release of two b results after that. Perhaps a buying opportunity coming up. From what I've gleaned, we're safer.